# Beta-Cell Function of Insulin Glargine Compared to Neutral Protamine Hagedorn (NPH) Insuline and to Insulin Detemir in Combination With Metformin

> **NCT00941148** · PHASE4 · COMPLETED · sponsor: **ikfe-CRO GmbH** · enrollment: 30 (actual)

## Conditions studied

- Type 2 Diabetic Patients
- Insufficient Metabolic Control
- OAD Treatment

## Interventions

- **DRUG:** Insulin Glargin
- **DRUG:** NPH insulin
- **DRUG:** Insulin detemir
- **DRUG:** metformin

## Key facts

- **NCT ID:** NCT00941148
- **Lead sponsor:** ikfe-CRO GmbH
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-04
- **Primary completion:** 2009-03
- **Final completion:** 2009-03
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2009-07-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00941148

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00941148, "Beta-Cell Function of Insulin Glargine Compared to Neutral Protamine Hagedorn (NPH) Insuline and to Insulin Detemir in Combination With Metformin". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00941148. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*